Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SSRI promising in the treatment of children and adolescents with OCD

Nov. 30, 1998

International study focuses on riluzole as a new approach to treating PD

Nov. 30, 1998

Nortran announces positive phase II trial results with RSD-921

Nov. 30, 1998

Human neural stem cells as source of transplantable cells for CNS disorders

Nov. 26, 1998

Grape polyphenols now shown to have neuroprotective properties

Nov. 26, 1998

Pharmacological profile of PNU-99194A, a D3-preferring dopamine antagonist, reviewed

Nov. 26, 1998

U.S. patent issues for conantokin-G and derivatives

Nov. 26, 1998

Antipsychotic drug dropped from Novartis pipeline

Nov. 25, 1998

Lilly's new glutamate receptor antagonists for pain

Nov. 25, 1998

Central alpha2-adrenoceptor antagonists claimed by Janssen for depression, Parkinson's disease

Nov. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...